BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 37873068)

  • 1. Distinct functions of EHMT1 and EHMT2 in cancer chemotherapy and immunotherapy.
    Kang Z; Fu P; Ma H; Li T; Lu K; Liu J; Ginjala V; Romanienko P; Feng Z; Guan M; Ganesan S; Xia B
    bioRxiv; 2023 Oct; ():. PubMed ID: 37873068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. De novo methylation of histone H3K23 by the methyltransferases EHMT1/GLP and EHMT2/G9a.
    Vinson DA; Stephens KE; O'Meally RN; Bhat S; Dancy BCR; Cole RN; Yegnasubramanian S; Taverna SD
    Epigenetics Chromatin; 2022 Nov; 15(1):36. PubMed ID: 36411491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Demethylation of EHMT1/GLP Protein Reprograms Its Transcriptional Activity and Promotes Prostate Cancer Progression.
    Besschetnova A; Han W; Liu M; Gao Y; Li M; Wang Z; Labaf M; Patalano S; Venkataramani K; Muriph RE; Macoska JA; Siegfried KR; Evans J; Balk SP; Gao S; Han D; Cai C
    Cancer Res Commun; 2023 Aug; 3(8):1716-1730. PubMed ID: 37663929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylation of DNA Ligase 1 by G9a/GLP Recruits UHRF1 to Replicating DNA and Regulates DNA Methylation.
    Ferry L; Fournier A; Tsusaka T; Adelmant G; Shimazu T; Matano S; Kirsh O; Amouroux R; Dohmae N; Suzuki T; Filion GJ; Deng W; de Dieuleveult M; Fritsch L; Kudithipudi S; Jeltsch A; Leonhardt H; Hajkova P; Marto JA; Arita K; Shinkai Y; Defossez PA
    Mol Cell; 2017 Aug; 67(4):550-565.e5. PubMed ID: 28803780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exon resequencing of H3K9 methyltransferase complex genes, EHMT1, EHTM2 and WIZ, in Japanese autism subjects.
    Balan S; Iwayama Y; Maekawa M; Toyota T; Ohnishi T; Toyoshima M; Shimamoto C; Esaki K; Yamada K; Iwata Y; Suzuki K; Ide M; Ota M; Fukuchi S; Tsujii M; Mori N; Shinkai Y; Yoshikawa T
    Mol Autism; 2014; 5(1):49. PubMed ID: 25400900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multi-omics analyses demonstrate a critical role for EHMT1 methyltransferase in transcriptional repression during oogenesis.
    Demond H; Hanna CW; Castillo-Fernandez J; Santos F; Papachristou EK; Segonds-Pichon A; Kishore K; Andrews S; D'Santos CS; Kelsey G
    Genome Res; 2023 Jan; 33(1):18-31. PubMed ID: 36690445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MDC1 methylation mediated by lysine methyltransferases EHMT1 and EHMT2 regulates active ATM accumulation flanking DNA damage sites.
    Watanabe S; Iimori M; Chan DV; Hara E; Kitao H; Maehara Y
    Sci Rep; 2018 Jul; 8(1):10888. PubMed ID: 30022091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tri-methylation of ATF7IP by G9a/GLP recruits the chromodomain protein MPP8.
    Tsusaka T; Kikuchi M; Shimazu T; Suzuki T; Sohtome Y; Akakabe M; Sodeoka M; Dohmae N; Umehara T; Shinkai Y
    Epigenetics Chromatin; 2018 Oct; 11(1):56. PubMed ID: 30286792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure, Activity, and Function of the Protein Lysine Methyltransferase G9a.
    Poulard C; Noureddine LM; Pruvost L; Le Romancer M
    Life (Basel); 2021 Oct; 11(10):. PubMed ID: 34685453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic priming by EHMT1/EHMT2 in acute lymphoblastic leukemia induces TP53 and TP73 overexpression and promotes cell death.
    Silva-Carvalho AÉ; Alencar APD; Resende MR; da Costa DF; Nonino A; Neves FAR; Saldanha-Araujo F
    Toxicol In Vitro; 2020 Dec; 69():104992. PubMed ID: 32889036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histone Methyltransferases G9a/
    Souza BK; Freire NH; Monteiro TS; Herlinger AL; Jaeger M; Dalmolin MGS; de Farias CB; Gregianin L; Brunetto AT; Brunetto AL; Thiele CJ; Roesler R
    Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TNFα Effects on Adipocytes Are Influenced by the Presence of Lysine Methyltransferases, G9a (EHMT2) and GLP (EHMT1).
    Able AA; Richard AJ; Stephens JM
    Biology (Basel); 2023 Apr; 12(5):. PubMed ID: 37237488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential patterns of histone methylase EHMT2 and its catalyzed histone modifications H3K9me1 and H3K9me2 during maturation of central auditory system.
    Ebbers L; Runge K; Nothwang HG
    Cell Tissue Res; 2016 Aug; 365(2):247-64. PubMed ID: 27083448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The lysine methyltransferase Ehmt2/G9a is dispensable for skeletal muscle development and regeneration.
    Zhang RH; Judson RN; Liu DY; Kast J; Rossi FM
    Skelet Muscle; 2016; 6():22. PubMed ID: 27239264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EHMT1 and EHMT2 inhibition induces fetal hemoglobin expression.
    Renneville A; Van Galen P; Canver MC; McConkey M; Krill-Burger JM; Dorfman DM; Holson EB; Bernstein BE; Orkin SH; Bauer DE; Ebert BL
    Blood; 2015 Oct; 126(16):1930-9. PubMed ID: 26320100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of cell differentiation and function by the euchromatin histone methyltranserfases G9a and GLP.
    Kramer JM
    Biochem Cell Biol; 2016 Feb; 94(1):26-32. PubMed ID: 26198080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual EZH2 and EHMT2 histone methyltransferase inhibition increases biological efficacy in breast cancer cells.
    Curry E; Green I; Chapman-Rothe N; Shamsaei E; Kandil S; Cherblanc FL; Payne L; Bell E; Ganesh T; Srimongkolpithak N; Caron J; Li F; Uren AG; Snyder JP; Vedadi M; Fuchter MJ; Brown R
    Clin Epigenetics; 2015; 7(1):84. PubMed ID: 26300989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. UHRF1 is associated with epigenetic silencing of BRCA1 in sporadic breast cancer.
    Jin W; Chen L; Chen Y; Xu SG; Di GH; Yin WJ; Wu J; Shao ZM
    Breast Cancer Res Treat; 2010 Sep; 123(2):359-73. PubMed ID: 19943104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of the G9a/GLP histone methyltransferase complex modulates anxiety-related behavior in mice.
    Wang DY; Kosowan J; Samsom J; Leung L; Zhang KL; Li YX; Xiong Y; Jin J; Petronis A; Oh G; Wong AHC
    Acta Pharmacol Sin; 2018 May; 39(5):866-874. PubMed ID: 29417943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EHMT1/EHMT2 in EMT, cancer stemness and drug resistance: emerging evidence and mechanisms.
    Nachiyappan A; Gupta N; Taneja R
    FEBS J; 2022 Mar; 289(5):1329-1351. PubMed ID: 34954891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.